Market Overview

25 Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Kalvista Pharmaceuticals Inc (NASDAQ: KALV) rose 85.6 percent to $13.70 in pre-market trading as the company reported a collaboration deal with Merck for KVD001.
  • AnaptysBio Inc (NASDAQ: ANAB) rose 14.3 percent to $40.00 in pre-market trading after the company issued topline proof-of-concept data from Phase 2a trial of ANB020 In atropic dermatits.
  • Vical Incorporated (NASDAQ: VICL) rose 12.7 percent to $3.11 in pre-market trading. Vicel reported closing of Phase 3 ASP0113 CMV vaccine trial.
  • Sphere 3D Corp. (NASDAQ: ANY) rose 12.5 percent to $3.25 in the pre-market trading session after surging 14.68 percent on Monday. Sphere 3D's Overland-Tandberg introduced its new rdxLOCK software.
  • McEwen Mining Inc (NYSE: MUX) rose 9.7 percent to $2.37 in pre-market trading after gaining 2.86 percent on Monday.
  • MannKind Corporation (NASDAQ: MNKD) shares rose 7.9 percent to $5.75 in pre-market trading. H.C. Wainwright initiated coverage on MannKind with a Buy rating and a $7.00 price target.
  • Ichor Holdings Ltd (NASDAQ: ICHR) rose 7.2 percent to $28.85 in pre-market trading. The company announced a "substantial" deal to produce liquid delivery systems for a key customer.
  • Truett-Hurst Inc (NASDAQ: THST) shares rose 6.7 percent to $2.25 in pre-market trading after gaining 1.93 percent on Monday.
  • DryShips Inc. (NASDAQ: DRYS) shares rose 6.5 percent to $3.46 in pre-market trading after declining 2.40 percent on Monday.
  • Marinus Pharmaceuticals Inc (NASDAQ: MRNS) rose 5.7 percent to $5.95 in pre-market trading after falling 18.93 percent on Monday.
  • Riot Blockchain Inc (NASDAQ: BIOP) shares rose 5.1 percent to $9.18 in the pre-market trading session after climbing 18.11 percent on Monday.
  • DRDGOLD Ltd. (ADR) (NYSE: DRD) rose 4.7 percent to $4.02 in pre-market trading after dropping 2.04 percent on Monday.
  • Recro Pharma Inc (NASDAQ: REPH) shares rose 4.7 percent to $8.99 in the pre-market trading session after the company disclosed Phase III IV meloxicam efficacy data in patients following abdominoplasty.
  • Moelis & Co (NYSE: MC) gained 4.7 percent to $44.05 after slipping 0.47 percent on Monday.
  • AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) rose 4.7 percent to $3.99 in pre-market trading after falling 0.78 percent on Monday.
  • Celsion Corporation (NASDAQ: CLSN) shares rose 3.8 percent to $3.86 in pre-market trading after surging 11.04 percent on Monday.
  • Wal-Mart Stores Inc (NYSE: WMT) shares rose 2.1 percent to $82.15 in pre-market trading after the company reported a $20 billion buyback plan and reaffirmed its FY18 adjustes earnings outlook.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Grupo Televisa SAB (ADR) (NYSE: TV) fell 8.4 percent to $21.52 in pre-market trading after declining 2.41 percent on Monday.
  • Conn's Inc (NASDAQ: CONN) fell 5.2 percent to $24.90 in pre-market trading after dropping 6.08 percent on Monday.
  • Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 4.6 percent to $20.12 in pre-market trading after surging 33.90 percent on Monday.
  • Zogenix, Inc. (NASDAQ: ZGNX) shares fell 4.5 percent to $37.30 after rising 1.96 percent on Monday.
  • Vericel Corp (NASDAQ: VCEL) fell 4.4 percent to $4.40 in pre-market trading after dropping 6.12 percent on Monday.
  • Izea Inc (NASDAQ: IZEA) shares fell 2.6 percent to $5.30 in pre-market trading after declining 7.95 percent on Monday.
  • American International Group Inc (NYSE: AIG) fell 2.1 percent to $60.50 in pre-market trading after giving an update on forecast third-quarter net catastrophe losses. The company is now expected net catastrophe losses in the $2.9 billion to $3.1 billion range.
  • Axalta Coating Systems Ltd (NYSE: AXTA) fell 2.1 percent to $29.06 in pre-market trading. Citigroup downgraded Axalta Coating from Neutral to Sell.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (AIG + ANAB)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...